norspan 20mg transdermal patch
mundipharma distribution gmbh (philippines branch) - buprenorphine - transdermal patch - 20mg
norspan tape 10mg (ノルスパンテープ10mg)
mundipharma k.k. - buprenorphine - beige patch, 45 mm x 68 mm
norspan tape 20mg (ノルスパンテープ20mg)
mundipharma k.k. - buprenorphine - beige patch, 72 mm x 72 mm
norspan tape 5mg (ノルスパンテープ5mg)
mundipharma k.k. - buprenorphine - beige patch, 45 mm x 45 mm
dhc continus
pharmaco (nz) ltd - dihydrocodeine hydrogen tartrate 60mg equivalent to dihydrocodeine 40 mg - modified release tablet - 60 mg - active: dihydrocodeine hydrogen tartrate 60mg equivalent to dihydrocodeine 40 mg excipient: cetostearyl alcohol hyetellose lactose monohydrate magnesium stearate purified talc - dhc continus is indicated for the management of severe pain where: - other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and -the pain is opioid-responsive, and -requires daily, continuous, long term treatment. dhc continus is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. dhc continus is not indicated as an as-needed (prn) analgesia.
butrans 10 micrograms/hour transdermal patch
imbat limited - buprenorphine - transdermal patch - 10 microgram per hour - oripavine derivatives; buprenorphine
butrans 5 micrograms/hour transdermal patch
imbat limited - buprenorphine - transdermal patch - 5 microgram per hour - oripavine derivatives; buprenorphine
butrans 20 micrograms/hour transdermal patch
imbat limited - buprenorphine - transdermal patch - 20 microgram per hour - oripavine derivatives; buprenorphine
butrans 10 micrograms/hour transdermal patch
mundipharma pharmaceuticals limited - buprenorphine - transdermal patch - 10 milligram(s) - oripavine derivatives; buprenorphine
butrans 20 micrograms/hour transdermal patch
mundipharma pharmaceuticals limited - buprenorphine - transdermal patch - 20 milligram(s) - oripavine derivatives; buprenorphine